Regenxbio (RGNX) Preferred Dividend Payments (2014 - 2015)
Regenxbio (RGNX) recorded quarterly Preferred Dividend Payments of $2.5 million in Q2 2015, up 431.39% quarter-over-quarter from -$755000.0 in Q1 2015.
Regenxbio (RGNX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Regenxbio's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.5 million for Q2 2015.
- In Q2 2015, Preferred Dividend Payments changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2015 stood at $1.7 million (changed N/A YoY), while the FY2015 annual figure was $1.7 million, up 114.36% from the prior year.
- Preferred Dividend Payments was $2.5 million for Q2 2015 at Regenxbio, up from -$755000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.5 million in Q2 2015 to a low of -$755000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2.50 Mn |
| Mar 31, 2015 | -755,000.00 |
| Dec 31, 2014 | 223,000.00 |
| Sep 30, 2014 | 126,000.00 |